Minimal residual disease in chronic myeloid leukaemia.

NC Cross - Hematology and cell therapy, 1998 - europepmc.org
The principle aim of residual disease analysis in patients with chronic myeloid leukaemia
(CML) is to gauge patient response to treatment and, in patients after allogeneic BMT, to …
被引用次数：67 相关文章

[引用][C] Minimal residual disease in chronic myeloid leukaemia

NCP CROSS - Hematology and cell therapy (Print), 1998 - pascal-francis.inist.fr
Minimal residual disease in chronic myeloid leukaemia CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Minimal residual disease in chronic myeloid leukaemia

NC Cross - Hematology and cell therapy, 1998 - pubmed.ncbi.nlm.nih.gov
The principle aim of residual disease analysis in patients with chronic myeloid leukaemia
(CML) is to gauge patient response to treatment and, in patients after allogeneic BMT, to …

[引用][C] Minimal residual disease in chronic myeloid leukaemia

NCP CROSS - Hematology and cell therapy, 1998 - Springer